CVX-FB5

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCVX-FB5
Drug Alias NameCVX-FB5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionApolipoprotein B-100 modulators
TargetsApolipoprotein B-100
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbcentra LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbcentra LLC
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A